285 related articles for article (PubMed ID: 20660763)
21. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis.
Arita M; Yoshida M; Hong S; Tjonahen E; Glickman JN; Petasis NA; Blumberg RS; Serhan CN
Proc Natl Acad Sci U S A; 2005 May; 102(21):7671-6. PubMed ID: 15890784
[TBL] [Abstract][Full Text] [Related]
22. A unique radioprotective effect of resolvin E1 reduces irradiation-induced damage to the inner ear by inhibiting the inflammatory response.
Zhang J; Xu A; Niu T; Liu C; Zhang Y; Li T; Wang J; Wang Y; Sun D
Radiat Oncol; 2020 Sep; 15(1):223. PubMed ID: 32977807
[TBL] [Abstract][Full Text] [Related]
23. Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation.
El Kebir D; Gjorstrup P; Filep JG
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14983-8. PubMed ID: 22927428
[TBL] [Abstract][Full Text] [Related]
24. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.
Kim SW; Kim HM; Yang KM; Kim SA; Kim SK; An MJ; Park JJ; Lee SK; Kim TI; Kim WH; Cheon JH
Inflamm Bowel Dis; 2010 Sep; 16(9):1514-25. PubMed ID: 20310012
[TBL] [Abstract][Full Text] [Related]
25. Resolvin E1 promotes resolution of inflammation in a mouse model of an acute exacerbation of allergic asthma.
Flesher RP; Herbert C; Kumar RK
Clin Sci (Lond); 2014 Jun; 126(11):805-14. PubMed ID: 24344649
[TBL] [Abstract][Full Text] [Related]
26. The effect of intestinal alkaline phosphatase on intestinal epithelial cells, macrophages and chronic colitis in mice.
Lee C; Chun J; Hwang SW; Kang SJ; Im JP; Kim JS
Life Sci; 2014 Apr; 100(2):118-124. PubMed ID: 24548630
[TBL] [Abstract][Full Text] [Related]
27. Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro.
Rey C; Nadjar A; Buaud B; Vaysse C; Aubert A; Pallet V; Layé S; Joffre C
Brain Behav Immun; 2016 Jul; 55():249-259. PubMed ID: 26718448
[TBL] [Abstract][Full Text] [Related]
28. Resolvin E1 receptor activation signals phosphorylation and phagocytosis.
Ohira T; Arita M; Omori K; Recchiuti A; Van Dyke TE; Serhan CN
J Biol Chem; 2010 Jan; 285(5):3451-61. PubMed ID: 19906641
[TBL] [Abstract][Full Text] [Related]
29. Resolvin E1 regulates adenosine diphosphate activation of human platelets.
Fredman G; Van Dyke TE; Serhan CN
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2005-13. PubMed ID: 20702811
[TBL] [Abstract][Full Text] [Related]
30. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury.
Seki H; Fukunaga K; Arita M; Arai H; Nakanishi H; Taguchi R; Miyasho T; Takamiya R; Asano K; Ishizaka A; Takeda J; Levy BD
J Immunol; 2010 Jan; 184(2):836-43. PubMed ID: 20007539
[TBL] [Abstract][Full Text] [Related]
31. Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye.
de Paiva CS; Schwartz CE; Gjörstrup P; Pflugfelder SC
Cornea; 2012 Nov; 31(11):1299-303. PubMed ID: 22257864
[TBL] [Abstract][Full Text] [Related]
32. Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration.
Liu G; Gong Y; Zhang R; Piao L; Li X; Liu Q; Yan S; Shen Y; Guo S; Zhu M; Yin H; Funk CD; Zhang J; Yu Y
FASEB J; 2018 Oct; 32(10):5413-5425. PubMed ID: 29723062
[TBL] [Abstract][Full Text] [Related]
33. Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice.
Liu G; Liu Q; Shen Y; Kong D; Gong Y; Tao B; Chen G; Guo S; Li J; Zuo S; Yu Y; Yin H; Zhang L; Zhou B; Funk CD; Zhang J; Yu Y
Br J Pharmacol; 2018 Apr; 175(8):1205-1216. PubMed ID: 28925017
[TBL] [Abstract][Full Text] [Related]
34. Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis.
Hasturk H; Abdallah R; Kantarci A; Nguyen D; Giordano N; Hamilton J; Van Dyke TE
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1123-33. PubMed ID: 25792445
[TBL] [Abstract][Full Text] [Related]
35. Lupeol inhibits LPS-induced NF-kappa B signaling in intestinal epithelial cells and macrophages, and attenuates acute and chronic murine colitis.
Lee C; Lee JW; Seo JY; Hwang SW; Im JP; Kim JS
Life Sci; 2016 Feb; 146():100-8. PubMed ID: 26767626
[TBL] [Abstract][Full Text] [Related]
36. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.
Arita M; Bianchini F; Aliberti J; Sher A; Chiang N; Hong S; Yang R; Petasis NA; Serhan CN
J Exp Med; 2005 Mar; 201(5):713-22. PubMed ID: 15753205
[TBL] [Abstract][Full Text] [Related]
37. Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions.
Arita M; Oh SF; Chonan T; Hong S; Elangovan S; Sun YP; Uddin J; Petasis NA; Serhan CN
J Biol Chem; 2006 Aug; 281(32):22847-54. PubMed ID: 16757471
[TBL] [Abstract][Full Text] [Related]
38. Deficiency of Protein Tyrosine Phosphatase Non-Receptor Type 2 in Intestinal Epithelial Cells Has No Appreciable Impact on Dextran Sulphate Sodium Colitis Severity But Promotes Wound Healing.
Kasper SH; Spalinger MR; Leonardi I; Gerstgrasser A; Raselli T; Gottier C; Atrott K; Frey-Wagner I; Fischbeck-Terhalle A; Rogler G; Scharl M
Digestion; 2016; 93(4):249-59. PubMed ID: 27115526
[TBL] [Abstract][Full Text] [Related]
39. Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin.
Salic K; Morrison MC; Verschuren L; Wielinga PY; Wu L; Kleemann R; Gjorstrup P; Kooistra T
Atherosclerosis; 2016 Jul; 250():158-65. PubMed ID: 27236706
[TBL] [Abstract][Full Text] [Related]
40. Pro-Resolving Mediator Resolvin E1 Restores Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome.
Luo J; Zhang WY; Li H; Zhang PH; Tian C; Wu CH; Zhao AN; Chen ML; Guo YF; Cho YC; Jin SW; Hao Y
Shock; 2022 Apr; 57(4):565-575. PubMed ID: 35271545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
